Expensive Endings: Reining In the High Cost of End-of-Life Care in Canada

32 Pages Posted: 1 Jun 2022

See all articles by Kieran L. Quinn

Kieran L. Quinn

University of Toronto

Sarina R. Isenberg

Bruyère Research Institute

James Downar

University of Ottawa - Department of Medicine

Date Written: October 21, 2021

Abstract

Canadians spend more on end-of-life care than other high-income countries, including the United States, yet we achieve poor results compared to most. There are structural factors and inefficiencies within our healthcare system that facilitate unhelpful and unwanted medical interventions at the end of life. In this Commentary, we review these factors and suggest several structural changes to address the high costs for healthcare and low satisfaction for patients.

A major avenue to cost saving is greater use of palliative care, rather than more costly acute care, in end-of life treatment. Palliative care primarily focuses on improving comfort and quality of life, often avoiding hospital-based, invasive, costly and potentially inappropriate care. Palliative care is preferably (but not always) delivered outside of acutecare settings, including in patients’ homes. People approaching the end of life (EOL) often require an intensification of healthcare services, and at least three in four would potentially benefit from palliative care prior to death.

Yet, only one in five Ontarians, for example, receives a physician home visit or palliative homecare in their last year of life, and only half receive palliative care in any setting. Instead, most Canadians facing their end of life receive acute care without a palliative focus. As a result, the cost of healthcare delivery increases significantly in the final months of life and does so in particular for hospital admissions and emergency room visits.

Several structural problems exacerbate the situation and need to be addressed. They include:

(i) Inadequate EOL beds and options. There are limited options for patients who require support as they near the end of life. In-patient palliative-care units and residential hospice beds may be appropriate for people with significant symptom control and supportive needs, but there are so few such beds available that admission is usually restricted to people in the final weeks of life.

(ii) Siloing of budgets. Canadian healthcare budgets are siloed by sector. Acute-care beds are substantially more expensive than hospice or in-patient palliative-care beds, long-term care (LTC) beds or homecare. If budgets were global, then we would find efficiencies by increasing capacity in lower-cost settings to reduce backlogs in higher-cost settings. But since each sector or organization manages its own budget, it is more difficult to enact decisions that increase costs in one sector that will ultimately reduce costs by a larger amount in another sector.

(iii) Lack of timely prompts to transition to a palliative approach. Since our healthcare system all too often uses acute-care options by default, patients must transition to a palliative approach early enough to experience the benefits of this approach and avoid EOL visits to the emergency room, hospital and the intensive care unit.

(iv) Barriers to home and community-care resources. There are some notable barriers to increasing the use of homecare for patients nearing the end of life. These barriers cannot be overcome by increasing the number of available caregiver hours.

If implemented, the structural changes we recommend could result in substantial improvement in end-of-life care and potentially save hundreds of millions of dollars annually for the Canadian healthcare system.

Note:
Funding Information: no relevant funding information to provide/declare.

Declaration of Interests: arina Isenberg: From December 2017-March 2022, I served as an Advisory Member on the Data Information and Advisory Committee, Ontario Palliative Care Network. From January 2022-present, I serve as a Director of St. Joseph’s Villa Foundation Board of Directors. James Downar: No declared conflicts. Michael Bonares: No declared conflicts. Kali Barrett: I have received consulting fees from Xenios AG for work relating to a planned economic evaluation of extracorporeal CO2 removal for patients with severe COPD. Peter Tanuseputro: No declared conflicts. Konrad Fassbender: I do not perceive any conflicts. I have $7.6 M in funding from Alberta Health to implement an awareness campaign for palliative care, advance care planning and to implement an Alberta Framework for palliative care competencies. My salary is provide to the University of Alberta from Covenant Health. Amy Hsu: No declared conflicts Kwadwo Kyeremanteng: I'm a medical advisor for Edward LifeSciences and Inspir Labs.

Keywords: Health policy, government policy, regulation, analysis of health care markets

JEL Classification: I18; I11

Suggested Citation

Quinn, Kieran L. and Isenberg, Sarina R. and Downar, James, Expensive Endings: Reining In the High Cost of End-of-Life Care in Canada (October 21, 2021). C.D. Howe Institute Commentary No. 608, 2021, Available at SSRN: https://ssrn.com/abstract=4096093 or http://dx.doi.org/10.2139/ssrn.4096093

Kieran L. Quinn

University of Toronto ( email )

105 St George Street
Toronto, M5S 3G8
Canada

Sarina R. Isenberg

Bruyère Research Institute ( email )

43 Bruyère Street
Ottawa, Ontario K1N 5C8
Canada

James Downar (Contact Author)

University of Ottawa - Department of Medicine

Canada

Do you have a job opening that you would like to promote on SSRN?

Paper statistics

Downloads
55
Abstract Views
557
Rank
749,697
PlumX Metrics